| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |